Genequantum Healthcare (SUZHOU) Co., Ltd.
USPTO PatentsView assignee record - 14 granted patents across 9 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Genequantum ranks #19,808 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 9 technology areas.
- #19,808
- of 49,997 US assignees by volume
- Top 13%
- by Innovation Score (50.3/100)
- 17.1
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R19808 · Foreign Corporation #19,808 · 14 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 14 grants
- MID-PACK #19,808/49,997
- PHOTO-FINISH G-form
- CPC-NARROW C07K · 9 areas
- INNOV-PAR 50.3/100
- CLAIMS-RICH 17.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2021–2025 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: G-form LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Genequantum’s 50.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Genequantum
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Genequantum… · this assignee
Genequantum… · this assignee
50 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Genequantum's Innovation Score is 50.3/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Genequantum?
Each dot is one of Genequantum’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Genequantum’s own 17.1 claims/patent is ABOVE the 11.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Genequantum's grants concentrate
Genequantum Healthcare (SUZHOU) Co., Ltd. is a focused PatentsView assignee: 9 CPC subclasses with 78.6% of grants classified under C07K (Peptides). Peak complete grant year is 2023 (5 grants) versus a trough of 1 in 2021. By volume, Genequantum sits between G-form LLC and GIST(Gwangju Institute of Science and Technology).
Genequantum's three-year grant acceleration
Genequantum Healthcare (SUZHOU) Co., Ltd. shows 10 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Genequantum's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- G-form
G-form LLC
14 patents
- Galtronics USA
Galtronics USA, Inc.
14 patents
- Gatekeeper Innova…
Gatekeeper Innovation, Inc.
14 patents
- GCS
GCS Co., Ltd.
14 patents
- Genicook Product
Genicook Product, LLC
14 patents
- Gerber Technology
Gerber Technology LLC
14 patents
- GF Machining Solu…
GF Machining Solutions SA
14 patents
- GIST(Gwangju Inst…
GIST(Gwangju Institute of Science and Technology)
14 patents
- Genequantum Healt… ◀
Genequantum Healthcare (SUZHOU) Co., Ltd.
14 patents
What this shows Genequantum holds 14 patents at rank #19,802, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Genequantum
By rank, the assignees closest to #19,802 in granted patent volume.
- G-form LLC #19,798 · 14 patents
- Galtronics USA, Inc. #19,799 · 14 patents
- Gatekeeper Innovation, Inc. #19,800 · 14 patents
- GCS Co., Ltd. #19,801 · 14 patents
- Genicook Product, LLC #19,803 · 14 patents
- Gerber Technology LLC #19,804 · 14 patents
- GF Machining Solutions SA #19,805 · 14 patents
- GIST(Gwangju Institute of Science and Technology) #19,806 · 14 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Genequantum's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Genequantum's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
50 Top 13% higher than 87% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 7.1% |
| 2022 | 1 | 7.1% |
| 2023 | 5 | 35.7% |
| 2024 | 4 | 28.6% |
| 2025partial year | 3 | 21.4% |
Which technologies does Genequantum Healthcare (SUZHOU) Co., Ltd. patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Genequantum Healthcare (SUZHOU) Co., Ltd.'s patent record in context - here's where to go next.
- Genequantum Healthcare (SUZHOU) Co., Ltd.'s lead technology class is C07K (Peptides), 78.6% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #19,808 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Genequantum Healthcare (SUZHOU) Co., Ltd. against G-form LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 50.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.